Drent M - Search Results

1

Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.

Mostard RL, Verschakelen JA, van Kroonenburgh MJ, Nelemans PJ, Wijnen PA, Vöö S, Drent M. Mostard RL, et al. Among authors: drent m. Respir Med. 2013 Mar;107(3):439-47. doi: 10.1016/j.rmed.2012.11.011. Epub 2012 Dec 19. Respir Med. 2013. PMID: 23261309 Free article.

2

Relationship between respiratory muscle function and quality of life in sarcoidosis.

Wirnsberger RM, Drent M, Hekelaar N, Breteler MH, Drent S, Wouters EF, Dekhuijzen PN. Wirnsberger RM, et al. Among authors: drent m, drent s. Eur Respir J. 1997 Jul;10(7):1450-5. doi: 10.1183/09031936.97.10071450. Eur Respir J. 1997. PMID: 9230229 Free article.

3

Evaluation of quality of life in sarcoidosis patients.

Wirnsberger RM, de Vries J, Breteler MH, van Heck GL, Wouters EF, Drent M. Wirnsberger RM, et al. Among authors: drent m. Respir Med. 1998 May;92(5):750-6. doi: 10.1016/s0954-6111(98)90007-5. Respir Med. 1998. PMID: 9713635 Free article.

4

Association of fatigue with an acute phase response in sarcoidosis.

Drent M, Wirnsberger RM, de Vries J, van Dieijen-Visser MP, Wouters EF, Schols AM. Drent M, et al. Eur Respir J. 1999 Apr;13(4):718-22. doi: 10.1034/j.1399-3003.1999.13d03.x. Eur Respir J. 1999. PMID: 10362029 Free article.

5

Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?

Drent M, Jacobs JA, de Vries J, Lamers RJ, Liem IH, Wouters EF. Drent M, et al. Eur Respir J. 1999 Jun;13(6):1338-44. doi: 10.1183/09031936.99.13613459. Eur Respir J. 1999. PMID: 10445609 Free article.

6

Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used?

De Vries J, Seebregts A, Drent M. De Vries J, et al. Among authors: drent m. Respir Med. 2000 Mar;94(3):273-8. doi: 10.1053/rmed.1999.0736. Respir Med. 2000. PMID: 10783939 Free article.

7

Sarcoidosis: assessment of disease severity using HRCT.

Drent M, De Vries J, Lenters M, Lamers RJ, Rothkranz-Kos S, Wouters EF, van Dieijen-Visser MP, Verschakelen JA. Drent M, et al. Eur Radiol. 2003 Nov;13(11):2462-71. doi: 10.1007/s00330-003-1965-x. Epub 2003 Jun 17. Eur Radiol. 2003. PMID: 12811502

8

The relationship between fatigue and clinical parameters in pulmonary sarcoidosis.

De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M. De Vries J, et al. Among authors: drent m. Sarcoidosis Vasc Diffuse Lung Dis. 2004 Jun;21(2):127-36. Sarcoidosis Vasc Diffuse Lung Dis. 2004. PMID: 15281434

9

Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis.

Hoitsma E, Faber CG, van Kroonenburgh MJ, Gorgels AP, Halders SG, Heidendal GA, Kessels AG, Reulen JP, Drent M. Hoitsma E, et al. Among authors: drent m. Sarcoidosis Vasc Diffuse Lung Dis. 2005 Mar;22(1):43-50. Sarcoidosis Vasc Diffuse Lung Dis. 2005. PMID: 15881279

10

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.

Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R, Albera C, Brutsche M, Davis G, Donohue JF, Müller-Quernheim J, Schlenker-Herceg R, Flavin S, Lo KH, Oemar B, Barnathan ES; Sarcoidosis Investigators. Baughman RP, et al. Among authors: drent m. Am J Respir Crit Care Med. 2006 Oct 1;174(7):795-802. doi: 10.1164/rccm.200603-402OC. Epub 2006 Jul 13. Am J Respir Crit Care Med. 2006. PMID: 16840744 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters